augmentin 250mg/125mg film-coated tablets
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 250 mg clavulanic acid 125 mg - antibacterials for systemic use
augmentin 875 mg/125 mg film-coated tablets
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 875 mg clavulanic acid 125 mg - antibacterials for systemic use
amoxicillin/clavulanic acid krka 500 mg/125 mg film-coated tablets
krka, d.d., novo mesto - amoxicillin; clavulanic acid - film-coated tablet - 500 mg/ 125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor - : antibacterials for systemic use, combinations of penicillins, incl. beta-lactamase inhibitors - - acute bacterial sinusitis (adequately diagnosed) - acute otitis media - acute exacerbations of chronic bronchitis (adequately diagnosed) - community acquired pneumonia - cystitis - pyelonephritis - skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis. - bone and joint infections, in particular osteomyelitis.
amoxicillin (as trihydrate) + clavulanic acid 200mg/28.5mg/5ml powder for oral suspension
actimed distributions inc - amoxicillin (as trihydrate) , clavulanic acid - powder for oral suspension - 200mg/28.5mg/5ml
clavucill 200mg/50mg, tablets for dogs
v.m.d. n.v/s.a. - amoxicillin trihydrate; potassium clavulanate - tablet - 200, 50 mg/tablet - amoxicillin and enzyme inhibitor - dogs - antibiotics
kesium 50 mg / 12.5 mg chewable tablets for cats and dogs
ceva santé animale - amoxicillin; clavulanic acid - chewable tablet - 62.5 mg/tablet - amoxicillin and enzyme inhibitor - cats, dogs - antibacterial
amoxicillin and clavulanate potassium powder, for suspension
rebel distributors corp - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin anhydrous 400 mg in 5 ml - amoxicillin and clavulanate potassium is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: lower respiratory tract infections − caused by β-lactamase−producing strains of h. influenzae and m. catarrhalis . otitis media − caused by β-lactamase−producing strains of h. influenzae and m. catarrhalis . sinusitis − caused by β-lactamase−producing strains of h. influenzae and m. catarrhalis . skin and skin structure infections − caused by β-lactamase−producing strains of s. aureus , e. coli , and klebsiella spp. urinary tract infections − caused by β-lactamase−producing strains of e. coli , klebsiella spp. and enterobacter spp. while amoxicillin and clavulanate potassium is indicated only for the conditions listed above, infections caused by ampicillin-susceptible organisms are also amenable to treatment with amoxicillin and clavulanate potassium due to its amoxicillin content. therefore, mixed infections caused by ampicilli
amoxicillin 250mg capsules
medreich plc - amoxicillin trihydrate - oral capsule - 250mg
clavudale 200 mg/50 mg tablets for dogs
dechra regulatory b.v. - amoxicillin trihydrate; potassium clavulanate - tablet - 200, 50 mg/tablet - amoxicillin and enzyme inhibitor
amoxicillin/clavulanic acid ab 500 mg - 125 mg film-coat. tabl.
aurobindo sa-nv - amoxicillin trihydrate 573,4 mg - eq. amoxicillin 500 mg; clavulanic acid 125 mg - film-coated tablet - 500 mg - 125 mg - amoxicillin trihydrate 573.4 mg; clavulanic acid 125 mg - amoxicillin and enzyme inhibitor